Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maya H Buch

Showing results (71-80 of 180) with videos related to

Pageof 18
Sort By:
BMC Musculoskeletal Disorders|February 6, 2016
A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA)Raluca B Dumitru, Sarah Horton, Richard Hodgson, et al.
BMJ (Clinical Research Ed.)|August 6, 2010
Symmetrical polyarthritis. Time for treatment targets in rheumatoid arthritisPaul Emery, , Maya H Buch, et al.
The Lancet. Rheumatology|May 28, 2026
The role of health literacy in clinical, treatment, and work-related outcomes in people with inflammatory arthritis in England: a cross-sectional studyMrinalini Dey, Sam Norton, Andrew P Cope, et al.
Seminars in Arthritis and Rheumatism|November 17, 2021
Symptom experience of limited cutaneous systemic sclerosis from the Patients' perspective: A qualitative study<sup>✰,✰✰,★,★★</sup>Alain Lescoat, Susan L Murphy, Yen T Chen, et al.
Advances in Rheumatology (London, England)|June 14, 2025
Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseasesNicholas Black, Joshua Bradley, Fardad Soltani, et al.
Nature Reviews. Rheumatology|September 4, 2024
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseasesMaya H Buch, Ziad Mallat, Marc R Dweck, et al.
Scientific Reports|March 1, 2020
T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for managementFrederique Ponchel, Agata N Burska, Laura Hunt, et al.
Rheumatology (Oxford, England)|July 17, 2021
First pilot study of extracellular volume MRI measurement in peripheral muscle of systemic sclerosis patients suggests diffuse fibrosisRaluca B Dumitru, Alex F Goodall, David A Broadbent, et al.
BMJ Open|March 12, 2021
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: a scoping review protocolAlain Lescoat, David Roofeh, Whitney Townsend, et al.
Rheumatology and Therapy|September 20, 2022
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled TrialsMartin Bergman, Maya H Buch, Yoshiya Tanaka, et al.
Pageof 18

Showing results (71-80 of 180) with videos related to

Sort By:
Pageof 18
BMC Musculoskeletal Disorders|February 6, 2016
A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA)Raluca B Dumitru, Sarah Horton, Richard Hodgson, et al.
BMJ (Clinical Research Ed.)|August 6, 2010
Symmetrical polyarthritis. Time for treatment targets in rheumatoid arthritisPaul Emery, , Maya H Buch, et al.
The Lancet. Rheumatology|May 28, 2026
The role of health literacy in clinical, treatment, and work-related outcomes in people with inflammatory arthritis in England: a cross-sectional studyMrinalini Dey, Sam Norton, Andrew P Cope, et al.
Seminars in Arthritis and Rheumatism|November 17, 2021
Symptom experience of limited cutaneous systemic sclerosis from the Patients' perspective: A qualitative study<sup>✰,✰✰,★,★★</sup>Alain Lescoat, Susan L Murphy, Yen T Chen, et al.
Advances in Rheumatology (London, England)|June 14, 2025
Determinants of myocardial fibrosis in patients with immune-mediated inflammatory diseasesNicholas Black, Joshua Bradley, Fardad Soltani, et al.
Nature Reviews. Rheumatology|September 4, 2024
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseasesMaya H Buch, Ziad Mallat, Marc R Dweck, et al.
Scientific Reports|March 1, 2020
T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for managementFrederique Ponchel, Agata N Burska, Laura Hunt, et al.
Rheumatology (Oxford, England)|July 17, 2021
First pilot study of extracellular volume MRI measurement in peripheral muscle of systemic sclerosis patients suggests diffuse fibrosisRaluca B Dumitru, Alex F Goodall, David A Broadbent, et al.
BMJ Open|March 12, 2021
Domains and outcome measures for the assessment of limited cutaneous systemic sclerosis: a scoping review protocolAlain Lescoat, David Roofeh, Whitney Townsend, et al.
Rheumatology and Therapy|September 20, 2022
Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled TrialsMartin Bergman, Maya H Buch, Yoshiya Tanaka, et al.
Pageof 18